Showing posts with label placenta. Show all posts
Showing posts with label placenta. Show all posts

Tuesday, October 9, 2018

Women Are Dying From This: Taking Cesareans Seriously


When women have cesareans, they are rarely warned that a possible complication can be placental problems in future pregnancies.

Many women (and especially higher weight women) are pressured into cesareans in their first pregnancy. Many of these same women are counseled away from Vaginal Birth After Cesarean (VBAC) and into repeat cesareans in subsequent pregnancies.

Few of these women have been told that cesareans raise the risk for Placenta Accreta, a very serious complication, and that every cesarean increases the risk for it. I know *I* wasn't told this. This is a tremendous disservice to parents and to the importance of informed consent.

About Accreta

In Placenta Accreta, the fertilized egg implants near or on scar tissue in the uterus. This scar tissue is usually from a prior cesarean, but can also be from a D&C procedure, fibroid removals, a perforation from an IUD, or any uterine surgery or instrumentation. The placenta then grows into the uterine wall in this scar tissue. After the baby is born (often prematurely), the placenta can't separate properly and bleeding can become prolific. If the bleeding is not resolved, the mother can die.

There are degrees of Placenta Accreta. When the placenta grows into the uterine wall, that's Placenta Accreta. 

When the placenta invades the muscles of the uterus, that's known as Placenta Increta.

When the placenta grows through the uterine wall and into nearby organs like the bladder, that's called Placenta Percreta. All are extremely serious conditions, but percreta is the most serious of all.

The accreta rate has risen over the years as the cesarean rate has increased. Doctors are seeing more and more cases these days of what used to be a very rare complication. Some data indicate that the accreta rate has risen from about 1 in 4000 in the 1970s to about 1 in 533 now.

You can read more about this in my blog series on Placenta Accreta.
  • Part One - What Is Placenta Accreta?
  • Part Two - Life-Threatening Complication of Prior Cesarean 
  • Part Three - Risks to Mother and Baby
  • Part Four - Diagnosis, Treatment, and a Cautionary Story
The absolute numerical risk of accreta occurring in any one person is low, even with prior cesareans. Most women who have had cesareans will not experience an accreta. However, it is such a life-threatening condition that even a relatively small incidence carries a tremendous burden of complications, cost, and potential loss of life.

The more cesareans you have had, the greater the risk for accreta. In one very large study (Silver 2006), accreta was present in:
  • 0.24% of women undergoing their first cesarean (previously unscarred)
  • 0.31% of women undergoing their second cesarean (one prior cesarean)
  • 0.57% of women undergoing their third cesarean (two prior cesareans)
  • 2.13% of women undergoing their fourth cesarean (three prior cesareans)
  • 2.33% of women undergoing their fifth cesarean (four prior cesareans)
  • 6.74% of women undergoing their sixth or more cesarean (five or more prior cesareans)
This is why it is important to avoid automatic repeat cesareans and to keep VBAC a viable choice. Multiple repeat cesareans are the single most preventable factor for accretas. 

Accreta does sometimes occur after only one cesarean, like the woman in the video below, and that's why it's important to prevent a first cesarean whenever possible as well.

One Mother's Accreta Story

This mother had only had ONE prior cesarean, but still developed accreta with baby #2. Her first cesarean was a planned cesarean, urged by her OB. She was never warned that her cesarean meant accreta was a potential risk for the future.

THIS is why the high cesarean rate matters. On a case-by-case basis, a cesarean can be a good thing. But the public health implication of a high cesarean rate is that more women will develop life-threatening complications like placenta accreta, more babies will be born prematurely, and more women will die or experience permanent damage. Sometimes even after only one cesarean.

If we want to decrease maternal mortality rates and prevent complications from accreta, we MUST decrease cesarean rates. As the mother in the video below states:
A cesarean can be a life-saving intervention. The goal is not to eliminate cesareans. The goal is to make decisions regarding cesareans appropriately, and to recognize that even an uncomplicated cesarean and recovery can still put the mother at significant future risk....


She continues:
"There are too many cesareans now, 1 in 3 births, and researchers estimate that as many as 50% of those are unnecessary. 
And since a prior cesarean is a significant risk factor for developing a future accreta, that means that there are women developing accreta when it could have been prevented. So the easiest way to reduce the amount of accretas is to reduce cesarean levels... 
Women are dying from this, and mothers are dying from this. We need to take the risks of a cesarean seriously."


Saturday, October 15, 2016

Placenta Accreta Rates Reflect High Cesarean Rates and VBAC Bans


October is Accreta Awareness Month. The International Cesarean Awareness Network (ICAN) is featuring Accreta Awareness as part of its focus this month, and is promoting the importance of donating blood in order to help women who experience accretas.

Placenta Accreta is a condition in which the placenta attaches too deeply to the uterine wall, or actually grows into the uterine wall. Occasionally it even grows through the uterine wall and into adjoining tissues. This means the placenta can't separate during birth. It causes massive bleeding, and frequently requires a hysterectomy in order to control the bleeding. Placenta Accreta has about a 7% maternal mortality rate and is one of the most serious obstetric situations a woman can face.

You can read more about Placenta Accreta in my series about it here:

  • Part One: What Is Accreta?
  • Part Two: Life-Threatening Complication of Prior Cesarean
  • Part Three: Risks to Mother and Baby
  • Part Four: Diagnosis, Treatment, and a Cautionary Story

Accretas have several different risk factors, including maternal age, parity, smoking, infection, pregnancy after fertility treatment, and prior uterine procedures such as D&C or fibroid removal.

However, the strongest risk factor for accretas is a history of prior cesarean sections. The discovery of placenta previa (a low-lying placenta) in a woman with a history of prior cesareans is particularly predictive of an accreta.

In addition, the risk for accreta rises strongly as the number of prior cesareans increases. Silver 2006 found the following risk for accreta by number of prior cesareans:

  • First cesarean:                  0.24%
  • Second cesarean:             0.31%
  • Third cesarean:                0.57%
  • Fourth cesarean:              2.13%
  • Fifth cesarean:                 2.33%
  • Sixth or more cesarean:   6.74%

A recent large Nordic study found:
The risk of AIP [abnormally invasive placenta] increased seven-fold after one prior caesarean section (CS) to 56-fold after three or more CS.
Accretas are associated with poor outcomes, but very high-order repeat cesareans are particularly associated with poor outcomes.

Many accretas occur in women who have a cesarean in their first pregnancy and are automatically scheduled for repeat cesareans thereafter. Women who have larger families are particularly impacted. Yet many of these women say that they were never counseled about the risk of accreta with repeat cesareans. This is wrong. Informed consent should include discussions of all the risks of both VBAC and repeat cesareans.

Alarmingly, the incidence of placenta accreta cases seems to be on the rise. As noted by ACOG in the graphic above, this is likely in response to the rising cesarean rates. This reflects an increase in both primary cesareans and routine repeat cesareans as a result of de facto VBAC bans.

The increase in accretas is not just a U.S. phenomenon. A recent study from Hong Kong, where there is a high underlying cesarean rate, demonstrates that the rate of accreta increased over time as the cesarean rate increased. The authors note:
The overall rate of morbidly adherent placenta...increased from 0.17/1000 births in 1999-2003 to 0.79/1000 births in 2009-2013.
For such a rare condition, that's a significant increase. A similar result was found in an Italian region with a strong increase in cesarean rates over the years. Researchers found that:
The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s. During the same period, cesarean section rates increased from 17 to 64%. Prior cesarean section was the only risk factor showing a significant concomitant rise. Our results reinforce cesarean section as the most significant predisposing condition for placenta accreta.
One recent analysis concluded:
The incidence of placenta accreta has increased 13-fold since the early 1900s and directly correlates with the increasing cesarean delivery rate.
Alarmingly, the increase in accreta rates also seems to parallel the rise in maternal mortality rates over time. There are many other factors that play into the maternal mortality rate, mind, but the high cesarean rate and resulting accretas is one major piece of the puzzle.

If we hope to reduce the number of women impacted by accretas, we must reduce the cesarean rate. The authors of the recent Nordic study pointed this out, saying:
Our findings indicate that a lower CS rate in the population may be the most effective way to lower the incidence of AIP [Abnormally Invasive Placenta]. 
This means not only reducing the number of women who have first cesareans but also the number of women who have automatic repeat cesareans. In order to do that, we must increase access to VBACs. Far too many women have difficulty finding providers who will support them in labor after cesarean. Many hospitals have outright VBAC bans.

Of course, it's only fair to note that most women who have higher-order cesareans will not experience an accreta. However, accreta is such a serious and life-threatening condition that even relatively small incidences carry a huge burden of complications, cost, and potential loss of life. That's why it is vital that women have balanced risk counseling after a prior cesarean and real access to VBAC if they want it.

There are many birth stories online of women who have experienced accretas. It's important to emphasize that many of them have good outcomes, but also important to point out that many of them have challenging outcomes, and some of them have even had tragic outcomes.

This is the bottom line. Real women have died because of accretas, leaving their children motherless. Others have lost their uterus to hysterectomy or their babies to prematurity. Although I have not personally known anyone who died from accreta, I have known several women who have had very close near-misses due to accreta. Nearly all lost their uteri as a result of their accreta, and some lost their babies as well.

This is the real consequence of a too-high cesarean rate. This is why it's so important to avoid non-indicated cesareans and improve VBAC access. 

*If you can, give blood to help support women who have been affected by accreta. 


References

Support Groups


Accreta Studies

Semin Perinatol. 2012 Oct;36(5):315-23. doi: 10.1053/j.semperi.2012.04.013. Implications of the first cesarean: perinatal and future reproductive health and subsequent cesareans, placentation issues, uterine rupture risk, morbidity, and mortality. Silver RM. PMID: 23009962
Rates of cesarean delivery have substantially increased worldwide during the past 30 years. Indeed, almost one-third of deliveries in the United States are cesareans. Most cesareans are safe, and major complications are uncommon. However, there is a "concealed" downside to cesarean deliveries. There are rare but life-threatening morbidities that may occur, which are often overlooked because most cesareans go well. In addition, subsequent pregnancies are fraught with an increased risk of both maternal and fetal complications. The worst of these are associated with placental problems such as previa, abruption, and accreta. The risk dramatically worsens in patients with multiple repeat cesarean deliveries. This article will summarize and highlight the implications of the rising cesarean rate on maternal and fetal morbidity and mortality.
Hong Kong Med J. 2015 Dec;21(6):511-7. doi: 10.12809/hkmj154599. Epub 2015 Nov 6. Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Cheng KK1, Lee MM1. PMID: 26554269
OBJECTIVES: To identify the incidence of morbidly adherent placenta in the context of a rising caesarean delivery rate within a single institution in the past 15 years, and to determine the contribution of morbidly adherent placenta to the incidence of massive postpartum haemorrhage requiring hysterectomy. SETTING: A regional obstetric unit in Hong Kong. PATIENTS: Patients with a morbidly adherent placenta with or without previous caesarean section scar from 1999 to 2013. RESULTS: A total of 39 patients with morbidly adherent placenta were identified during 1999 to 2013. The overall rate of morbidly adherent placenta was 0.48/1000 births, which increased from 0.17/1000 births in 1999-2003 to 0.79/1000 births in 2009-2013. The rate of morbidly adherent placenta with previous caesarean section scar and unscarred uterus also increased significantly. Previous caesarean section (odds ratio=24) and co-existing placenta praevia (odds ratio=585) remained the major risk factors for morbidly adherent placenta. With an increasing rate of morbidly adherent placenta, more patients had haemorrhage with a consequent increased need for peripartum hysterectomy. No significant difference in the hysterectomy rate of morbidly adherent placenta in caesarean scarred uterus (19/25) compared with unscarred uterus (8/14) was noted. This may have been due to increased detection of placenta praevia by ultrasound and awareness of possible adherent placenta in the scarred uterus, as well as more invasive interventions applied to conserve the uterus. CONCLUSION: Presence of a caesarean section scar remained the main risk factor for morbidly adherent placenta. Application of caesarean section should be minimised, especially in those who wish to pursue another future pregnancy, to prevent the subsequent morbidity consequent to a morbidly adherent placenta, in particular, massive postpartum haemorrhage and hysterectomy.
Acta Obstet Gynecol Scand. 2013 Apr;92(4):457-60. doi: 10.1111/aogs.12080. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, Martinelli P. PMID: 23347183
...The aim of this study was to investigate the change in the incidence of placenta accreta and associated risk factors along four decades, from the 1970s to 2000s, in a tertiary south Italian center. We analyzed all cases of placenta accreta in a sample triennium for each decade. The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s. During the same period, cesarean section rates increased from 17 to 64%. Prior cesarean section was the only risk factor showing a significant concomitant rise. Our results reinforce cesarean section as the most significant predisposing condition for placenta accreta.
Obstet Gynecol. 2015 Sep;126(3):654-68. doi: 10.1097/AOG.0000000000001005. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Silver RM1. PMID: 26244528
Placental disorders such as placenta previa, placenta accreta, and vasa previa are all associated with vaginal bleeding in the second half of pregnancy. They are also important causes of serious fetal and maternal morbidity and even mortality. Moreover, the rates of previa and accreta are increasing, probably as a result of increasing rates of cesarean delivery, maternal age, and assisted reproductive technology....
BJOG. 2016 Jul;123(8):1348-55. doi: 10.1111/1471-0528.13547. Epub 2015 Jul 29. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadóttir RI, Tapper AM, Børdahl PE, Gottvall K, Petersen KB,Krebs L, Gissler M, Langhoff-Roos J, Källen K. PMID: 26227006
OBJECTIVE: The objective was to investigate prevalence, estimate risk factors, and antenatal suspicion of abnormally invasive placenta (AIP) associated with laparotomy in women in the Nordic countries. DESIGN: Population-based cohort study. SETTING AND POPULATION: A 3-year Nordic collaboration among obstetricians to identify and report on uterine rupture, peripartum hysterectomy, excessive blood loss, and AIP from 2009 to 2012 The Nordic Obstetric Surveillance Study (NOSS). METHODS: In the NOSS study, clinicians reported AIP cases from maternity wards and the data were validated against National health registries. MAIN OUTCOME MEASURES: Prevalence, risk factors, antenatal suspicion, birth complications, and risk estimations using aggregated national data. RESULTS: A total of 205 cases of AIP in association with laparotomy were identified, representing 3.4 per 10 000 deliveries. The single most important risk factor, which was reported in 49% of all cases of AIP, was placenta praevia. The risk of AIP increased seven-fold after one prior caesarean section (CS) to 56-fold after three or more CS. Prior postpartum haemorrhage was associated with six-fold increased risk of AIP (95% confidence interval 3.7-10.9). Approximately 70% of all cases were not diagnosed antepartum. Of these, 39% had prior CS and 33% had placenta praevia. CONCLUSION: Our findings indicate that a lower CS rate in the population may be the most effective way to lower the incidence of AIP. Focused ultrasound assessment of women at high risk will likely strengthen antenatal suspicion. Prior PPH is a novel risk factor associated with an increased prevalence of AIP.
Am J Obstet Gynecol. 2015 Sep;213(3):384.e1-11. doi: 10.1016/j.ajog.2015.05.002. Epub 2015 May 5. Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Creanga AA, Bateman BT, Butwick AJ, Raleigh L, Maeda A, Kuklina E, Callaghan WM. PMID: 25957019
OBJECTIVE: The purpose of this study was to examine cesarean delivery morbidity and its predictors in the United States. STUDY DESIGN: We used 2000-2011 Nationwide Inpatient Sample data to identify cesarean deliveries and records with 12 potential cesarean delivery complications, including placenta accreta. We estimated cesarean delivery morbidity rates and rate changes from 2000-2011, and fitted Poisson regression models to assess the relative incidence of morbidity among repeat vs primary cesarean deliveries and explore its predictors. RESULTS: From 2000-2011, 76 in 1000 cesarean deliveries (97 in 1000 primary and 48 in 1000 repeat cesarean deliveries) were accompanied by ≥1 of 12 complications. The unadjusted composite cesarean delivery morbidity rate increased by 3.6% only among women with a primary cesarean delivery (P < .001); the unadjusted rate of placenta accreta increased by 30.8% only among women with a repeat cesarean deliveries (P = .025). The adjusted rate of overall composite cesarean delivery morbidity decreased by 1% annually from 2000-2011 (P < .001). Compared with women with a primary cesarean delivery, those women who underwent a repeat cesarean delivery were one-half as likely (incidence rate ratio, 0.50; 95% CI, 0.49-0.50) to experience a complication, but 2.13 (95% CI, 1.98-2.29) times more likely to have a placenta accreta diagnosis. Both cesarean delivery morbidity and placenta accreta were positively associated with age >30 years, non-Hispanic black race/ethnicity, the presence of a chronic medical condition, and delivery in urban, teaching, or larger hospitals. CONCLUSION: Overall, cesarean delivery morbidity declined modestly from 2000-2011, but placenta accreta became an increasingly important contributor to repeat cesarean delivery morbidity. Clinicians should maintain a high index of suspicion for abnormal placentation and make adequate preparations for patients who need cesarean deliveries.
BJOG. 2013 Jan;120(1):85-91. doi: 10.1111/1471-0528.12010. Epub 2012 Oct 24. Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study. Cook JR1, Jarvis S, Knight M, Dhanjal MK. PMID: 23095012
OBJECTIVE: To estimate the incidence of multiple repeat caesarean section (MRCS) (five or more) in the UK and to describe the outcomes for women and their babies relative to women having fewer repeat caesarean sections. DESIGN: A national population-based prospective cohort study using the UK Obstetric Surveillance System (UKOSS). SETTING: All UK hospitals with consultant-led maternity units. POPULATION: Ninety-four women having their fifth or greater MRCS between January 2009 and December 2009, and 175 comparison women having their second to fourth caesarean section. METHODS: Prospective cohort and comparison identification through the UKOSS monthly mailing system. MAIN OUTCOME MEASURES: Incidence, maternal and neonatal complications. Relative risk, unadjusted (OR) and adjusted (aOR) odds ratio estimates. RESULTS: The estimated UK incidence of MRCS was 1.20 per 10 000 maternities [95% confidence interval (CI), 0.97-1.47]. Women with MRCS had significantly more major obstetric haemorrhages (>1500 ml) (aOR, 18.6; 95% CI, 3.89-88.8), visceral damage (aOR, 17.6; 95% CI, 1.85-167.1) and critical care admissions (aOR, 15.5; 95% CI, 3.16-76.0), than women with lower order repeat caesarean sections. These risks were greatest in the 18% of women with MRCS who also had placenta praevia or accreta. Neonates of mothers having MRCS were significantly more likely to be born prior to 37 weeks of gestation (OR, 6.15; 95% CI, 2.56-15.78) and therefore had higher rates of complications and admissions. CONCLUSIONS: MRCS is associated with greater maternal and neonatal morbidity than fewer caesarean sections. The associated maternal morbidity is largely secondary to placenta praevia and accreta, whereas higher rates of preterm delivery are most likely a response to antepartum haemorrhage.
Obstet Gynecol. 2011 Sep;118(3):687-90. doi: 10.1097/AOG.0b013e318227b8d9. The rising cesarean delivery rate in America: what are the consequences? Blanchette H1. PMID: 21860302
Cesarean delivery is now the most common operation in the United States, and it has increased dramatically from 5.8% in 1970 to 32.3% in 2008. This rise has not resulted in significant improvement in neonatal morbidity or maternal health. Three recent studies of elective repeat cesarean deliveries performed before 39 completed weeks of gestation have demonstrated increased respiratory and other adverse neonatal outcomes. Maternal mortality in the United States has increased from 10 per 100,000 to 14 per 100,000 from 1998 to 2004. Contributing to this in an increasing incidence of placenta accreta associated with multiple uterine scars requiring the need for emergency cesarean hysterectomy, blood transfusion, and maternal mortality due to obstetric hemorrhage. To reverse the trend of the rising cesarean delivery rate, obstetricians must reduce the primary rate and avoid the performance of a uterine incision unless absolutely necessary for fetal or maternal indications. For women with one previous low transverse cesarean delivery, obstetricians should promote a trial of labor after previous cesarean delivery in those women who desire three or more children.

Thursday, April 2, 2015

Give Blood for Those Who Give Life

Accreta Awareness Blood Drive - this month
April is Cesarean Awareness Month.

One of the results of a high cesarean rate is an increase in the risk for Placenta Accreta, where the placenta attaches too deeply into the uterus. This means the placenta has difficulty separating after the birth, greatly increasing the risk for life-threatening hemorrhage, hysterectomy, prematurity, and even death. 

Most people recognize the immediate risks of cesarean, which basically are the risks of any surgery: infection, bleeding, scar tissue, anesthesia problems. However, what many are not aware of are late complications from cesareans, those that occur in future pregnancies after a cesarean. In particular, the risk for abnormal placentation rises with each successive cesarean. These include:
  • placental abruption (the placenta shearing off before the baby is ready to be born) 
  • placenta previa (a low-lying placenta that covers or nearly covers the cervix)
  • placenta accreta (an abnormally attached placenta that has difficulty detaching after birth)
All of these can be life-threatening to both mother and baby, but placenta accreta is particularly serious. I've written about Placenta Accreta before in a 4-part series:
  • Part One - What Is Placenta Accreta?
  • Part Two - Life-Threatening Complication of Prior Cesarean 
  • Part Three - Risks to Mother and Baby
  • Part Four - Diagnosis, Treatment, and a Cautionary Story
Placenta Accreta is a real problem and one that is increasing all the time because the underlying cesarean rate is so high in some areas.

Keep in mind that the absolute numerical risk is low; most women who have had cesareans will not experience an accreta. However, the more cesareans you have had, the more at-risk for accreta you are. That's why it's so important that women not be forced into an automatic repeat c-section after a first cesarean, as women in many areas are due to VBAC bans in hospitals.

Some data indicates that the accreta rate has risen from about 1 in 4000 in the 1970s to about 1 in 533 these days. The main culprit in this is the increase in the number of cesareans, both primary but especially in repeat cesareans.

It's one thing when a cesarean truly saves a life; no one begrudges a truly necessary cesarean. It's a miracle that such technology and skill exists and it's a blessed intervention when applied appropriately. It's the cesarean done without medical indication that is the real problem, and VBAC bans in particular are putting more and more mothers and babies at risk.

Accreta Awareness Blood Drive

Brandy and her miracle baby
after a life-threatening accreta
I followed up my accreta series last year with Brandy's Story, where I told the story of an online friend who developed Placenta Accreta and hemorrhaged badly.

Normal blood loss in a vaginal birth is 500 ml; 1000 ml in a cesarean. Brandy lost 7,500 ml. That's seven THOUSAND five hundred; in other words, she had more than seven times the normal blood loss for a cesarean. Because the main artery of her placenta had burrowed deep into her cervix, she ended up losing her uterus. Thank goodness Brandy's baby survived, but Brandy lost her uterus, her future fertility, and nearly her life because previous doctors had pressured her into some cesareans she didn't truly need. 

Placenta Accreta is real and affects real women and babies. Do enough cesareans, and increasing numbers of women will face this devastating and life-threatening complication. 

As I've noted before, I've known several women now who have been affected by accreta; all suffered severe hemorrhages and several lost their fertility and uteri forever.

A different acquaintance of mine lost her baby and very nearly her life too. If she hadn't been transferred to a major regional hospital with a protocol and resources for extreme blood loss, she almost surely would have died (she came very close to death even with that protocol and multiple blood transfusions).

Although most women with accreta do survive, many suffer significant health consequences. And of course, occasionally women do die, usually of blood loss. Nationwide, we have seen a number of women who have lost their lives (or had near misses) from accreta.

Brandy almost lost her life too; she survived only because of massive blood transfusions. As a thank-you to the care providers who heroically helped save her life during her accreta surgery and as a thank-you to those who saved her life by giving blood previously, she started an Accreta Awareness Blood Drive.

So in April, in honor of Cesarean Awareness Month and all the mothers who have experienced accreta, please consider donating blood to the American Red Cross. Do it for the mothers who may experience severe bleeding during pregnancy due to accreta or other complications. Do it for the fathers, so they don't lose their wives. Do it for the families, so the children don't grow up without their mothers.

[Below is the publicity release from ICAN and places where you can donate to this specific campaign. Of course, if you don't have a Hope for Accreta Awareness campaign event near you or cannot donate this month, you can always call the Red Cross and just donate blood at one of their regular events.] 
The International Cesarean Awareness Network is pleased to be participating in this year's Accreta Awareness Blood Drive occurring nationwide on April 3rd in support of the Hope for Accreta Foundation.  
The purpose of this blood drive is to raise awareness of placenta accreta, a condition in which the placenta attaches itself too deeply into the uterus. Placenta accreta is also a risk of repeat cesarean whose treatment often requires emergency blood transfusion after birth.

In July of 2012, the American College of Obstetricians and Gynecologists issued a committee opinion on placenta accreta. It stated that "the incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate." Additionally, they also stated that "women at greatest risk of placenta accreta are those who have myometrial damage caused by a previous cesarean delivery with either anterior or posterior placenta previa overlying the uterine scar. The authors of one study found that in the presence of a placenta previa, the risk of placenta accreta was 3%, 11%, 40%, 61%, and 67% for the first, second, third, fourth, and fifth or greater repeat cesarean deliveries, respectively." (1)

In light of this, it is now more important than ever that women be made fully aware of placenta accreta. Find a blood drive near you! Click here for a list of blood drives available. 
Support Groups for Women with Accreta:
*post edited 4/3/15 to include some additional links

Saturday, April 19, 2014

Placenta Accreta: Brandy's Story

Brandy and her 7th baby postpartum
Notice the large central IV line in her neck and IV line in her arm for quick blood transfusion

As part of Cesarean Awareness Month, we are drawing attention to the high cesarean rate and the public health implications of too many cesareans.

One of the complications of multiple cesareans is that the placenta in a subsequent pregnancy can implant too low in the uterus (placenta previa) or grow into the uterine wall (placenta accreta).

This can cause life-threatening complications, including premature birth, impaired growth, or stillbirth for the baby, and severe hemorrhage, hysterectomy, and even death for the mother. Placental abruption (placenta detaching too early) is another potential risk after a prior cesarean.

We've written about placental complications after cesarean before. As a brief reminder, there are three levels of severity in accretas:
  1. Accreta (placenta is abnormally attached to uterus and can't detach easily after birth)
  2. Increta (placenta grows into the wall of the uterus and cannot detach after birth)
  3. Percreta (placenta grown through the wall of the uterus and into surrounding organs)
Image Source: Reitman 2011, Anesthesiology

[If you are looking for more technical information about placenta accreta, see Part One (what is accreta, how a placenta works), Part Two (risk factors, symptoms, and incidence of accreta), Part Three (risks to mother, baby, and future pregnancies), and Part Four (diagnosis and treatment) of my prior series on placenta accreta.]

This time, rather than writing about what accreta is and how to manage it, we present the first-hand story of one mother's experience with placenta accreta (increta in her case). 

It's important to remember that placenta accreta is real and affects real women and babies. Do enough cesareans, and increasing numbers of women will face this devastating and life-threatening complication. I've known several women now who have been affected by this condition; all suffered severe hemorrhages and several lost their fertility and uteri forever. One lost her baby and very nearly her life too.

That's why it's so important to do cesareans only when medically indicated and to keep VBAC (Vaginal Birth After Cesarean) an option for those who want it.

Brandy's Story

Brandy has had 7 births and 2 miscarriages. 3 of her births were by cesarean.

Yes, high parity is a risk factor for placental complications, but multiple cesareans is a stronger risk factor. Combine the two and the risks multiply.

Her first birth was a c-section after mismanagement by her doctor. She was told she'd never deliver a baby over 8 lbs. and that her babies were "too big" for her to deliver vaginally. She developed a terrible infection and wasn't allowed to hold her baby for 3 days.

Her second birth was a VBAC at 32 weeks. The placenta detached prematurely and baby might have had some lack of oxygen issues. He passed away at 21 months from seizures.

She miscarried her next pregnancy. Her third birth was another VBAC. She had to fight hard for it when her labor stalled for a little while but in the end she had a VBAC.

Her fourth birth was a CBAC (Cesarean Birth After Cesarean). She had a big baby (10 lbs.) and her doctor scared her into a repeat cesarean because of a recent shoulder dystocia in the practice.

Her fifth birth was another CBAC. Her doctor was opposed to a VBA2C. After her water broke and labor did not start for several days, she had the repeat cesarean. The doctor said she had very little scarring and could have more children. The risks of multiple cesareans, including accreta, were never mentioned.

In her next pregnancy, Brandy weighed the potential risks of VBAC after multiple cesareans against the cumulative risks of multiple cesareans and chose VBAC. She stayed at home in order to have a supportive provider. Her sixth baby was a homebirth VBA3C. He was 11 lbs. 4 oz., three lbs. bigger than her first doctor said she could ever birth vaginally.

She had another miscarriage again, then became pregnant a few months later. She planned another VBAC. Unfortunately, this time the fertilized egg implanted low, near the cervix (placenta previa) and the placenta grew into the uterine wall and into the cervix itself (placenta increta).

In the end she lost her uterus and most of her cervix and suffered a severe hemorrhage but was very fortunate to escape with her baby and her life.

This is the story of Brandy's placenta accreta pregnancy and birth.

I was so excited when I found out I was pregnant. I was also very scared since I had just miscarried 8 months prior. At 7 weeks when I started spotting I just knew something was wrong. I had no idea what the real problem was and what I would end up facing.

I decided to go to the ER and get checked. It was a pleasant surprise to see a healthy little heart beat. I did notice on my discharge paper that it was noted that the placenta had attached to the lower uterine segment.

A week went by and I was still spotting. I called my OB and they decided to schedule a ultrasound to check on things. The ultrasound tech noted that I had a short cervical length. I was sent to a perinatologist to see if they wanted to place a stitch. I was very confused. I had already carried 6 other children. I did deliver one of my babies at 32 weeks, but I never had a incompetent cervix.

The perinatologist quickly pointed out that I had a complete posterior placenta previa. I was so upset; I knew that would mean another c-section. I had already had 3 c-sections; I did not want another. I had already begun dreaming of another beautiful HBA3C. I had it in my head how I was gonna make a music list and dance through labor. I was gonna walk around outside in the nice cool October weather. I was looking forward to feeling every contraction and being more relaxed this time since it would be my 2nd HBA3C. [kmom note: Home Birth After 3 Cesareans]

Time went on and I continued to get ultrasounds monthly. It was always the same thing...the placenta had not moved. I was still spotting everyday; it was there every time I wiped. At one ultrasound appointment my OB made a comment that she saw a lot of placental lakes. I started researching placental lakes and learned that they are seen a whole lot with accreta. I started to worry.

I finally got good news at my 20 week ultrasound. The perinatologist said it looked like the placenta had moved and it was only the tip of it covering my cervix. He did say that there was a blood clot covering the cervix now, but that my body should reabsorb it. I questioned him a little bit about the blood clot. He reminded me that I had been spotting and that is what it was from. I had noticed the spotting had been slowing down so it all made sense. It was good news! The placenta moved some and I had a healthy baby boy. No one had to tell me I was having a boy; he decided to show off for momma.

I left the doctor's office practically skipping. I went and bought a bunch of "It's a Boy" balloons and filled a bag with them to let my other kids tear open. We were all so happy and back to planning our home birth.

At the next ultrasound I was 24 weeks and I just knew they were gonna tell me the placenta had moved more.  The look on the ultrasound tech's face said something was wrong. When she told me she wanted the doctor to see it I felt my stomach go into my throat. 

Two minutes felt like a century as the doctor was looking at the ultrasound. He said, “What I believed was a blood clot last appointment actually looks like a accreta.” He then went on to say that unfortunately with your c-section history and what this looks like, it I am pretty sure we will have to take your womb. 

He went on to show me how vascular one section of the uterus was. He continued to talk about unfortunately this is like the weather, there is nothing you can do about it. He continued to talk and all I heard was some mumble about any OB can do a hysterectomy and I should be able to deliver at my local hospital.

I was numb, how could this be. I waited at the check-out desk trying to breathe, trying not to cry. I got my card for my next appointment as the tears started to fall. I don’t know how I walked to my car. My phone rang and I could not get out hello.

After I had a little while to process things and talk to a few people I decided to go to get a second opinion in Baltimore. The blood clot theory made sense. My spotting stopped at 22 weeks.  I figured that was a good sign. The specialist in Baltimore knew more about accreta and could give me better answers.

Once I got to my appointment in Baltimore, that look the first tech had, I saw it all over again. This look of fear, maybe even confusion, just like the tech before she went to go get the doctor. He showed me that the placenta was supposed to look black on the ultrasound and there was these weird gray areas. He told me that at the least we were dealing with increta, but that he believed it was percreta. 

He went on to say all my care would be transferred there. That with this condition there would be massive blood loss and my local hospital could not handle delivering me. I tried to be strong but I burst into tears. We decided to do a MRI to try to get a better ideal if any of my other organs were involved.

Everything then just became a blur. I spent every Monday in Baltimore seeing doctors and having ultrasounds. The group of specialist were waiting on the MRI results to decide whether to deliver closer to 34 or 36 weeks.

Once the MRI results came back it looked like no other organs were involved but that the placenta was invading the uterine wall. I was so happy to get the news that none of my other organs were involved. That was the first time through all of this I got good news. It is funny looking back now how wonderful that news really was to me.  Since I was doing good and had no bleeds they decided to schedule my c-section at 36 weeks. Some of the doctors were still hopeful that once they got in there the placenta would detach easily.

I had 6 weeks until delivery and I was trying to understand and accept things. I was terrified. I felt like a ticking time bomb. I could not sleep. My husband was working nights so I was alone with 4 little ones, eight and under. I was scared I would have a bleed in the middle of the night and the kids would be terrified. When I did sleep I would have nightmares of having a c- section and my incision opening up and I was standing there holding my insides. 

I would hold my little ones and wonder if  I would be able to see them grow up. I would think, "My 2 year-old will not remember me." I think all these thoughts but had no patience with my kids. Then I would think if I don’t make it all they will remember is me snapping at them. 

One of the hardest things I had to deal with was knowing that the people that got me here by doing 3 unnecessary c-sections on me were the same people I now had to trust to get me out of this.

As the weeks went by I realized that I had no control over the outcome. I had to do the best I could and control what I could and give the rest to God.  I had to believe that even if I did not make it through that God would take care of my kids and it would be OK.

Days before my delivery I had to go do pre-op blood work and meet with anesthesia. I was told with the blood loss they were expecting I may have a lot of swelling and fluid in my lungs. They may have to keep me asleep until Friday until the swelling went down. They wanted my family to be prepared. That broke my heart to think I may not see my baby on the day he was born. They said I would go home with a bladder bag if they had to do the hysterectomy. With the scar tissue from my c-section they were sure that they would rip my bladder when they removed my uterus.

Delivery day came saying good bye to my kids was one of the hardest things I ever had to do. They were so excited to meet their brother the next day. And I had no idea if I would ever meet my baby or see my other kids again. 

I got to the hospital around midnight. They got me situated in my room and then let me sleep for a few hours. I would doze off for a few minutes then wake back up with a knot in my stomach and a lump in my throat. I didn't want to be there. I wanted to run far far away from that place.

At 6 a.m. they came in and started to get me prepped for surgery. We had decided that it was best for me to just be put under general. My surgeon was afraid he would lose time if I began to hemorrhage and they had to put me under then. They did not want the baby to be under general any longer then he had to. 

All the prep was done in my room. Anesthesia came and placed a central line in my neck and a large IV in my wrist; both of those were for blood transfusion. They also placed a monitor in my wrist that would send labs and gives them second-by-second blood pressure reading. By this time I was numb, I had shut down. I just prayed and sang worship songs in my head and took myself away from there.

My surgeon came in and did a quick ultrasound to see where he was gonna cut.  As funny as it sounds I was still hoping that he was gonna find that the placenta had moved.

Once it was time to go to the OR the two main surgeons wheeled me down. My husband got off on another floor to wait in the waiting room. I just wanted to scream, “NO!” I didn't want my husband to go. I wanted him there when I fell asleep. I just gave him a kiss and told him I will see you in little while. He said a quick prayer and slipped off the elevator.

We were outside the O.R. doors and had to wait. The blood bank had not brought down the blood that was to be on stand-by in the O.R. There were doctors everywhere. My neck hurt so bad from the central line. I could barely move. And there was so many people coming up introducing themselves. MY nurse kept saying, “Oh my goodness, everyone is here.” She said, "You have the best of the best!"

All of a sudden here comes two big coolers. I just hear everyone say, “OK, let's go.” My surgeon told me, "I have been resting for 2 days for your surgery." 

I said, “Hey, you have to take good care of me. I have lots of little ones that need me.” He said, “Brandy, we know what you got and we are gonna take good care of you.”

Things got real busy in the O.R., they put the oxygen mask on me, and kept telling me to to take nice slow breaths. The mask made me feel like I could not breathe. I was getting frustrated that I was not asleep yet. I wanted it over. No matter what the outcome was gonna be I was ready to get there. Everyone was rubbing my arms telling me that they were there and they aren't gonna leave, that I was OK. I remember thinking I am never gonna fall asleep.

I heard, "Don’t talk, you still have the breathing tube in." I raised my arm and started to write in the air. The nurse got me a paper and pen. I wrote "b" and dozed off, I wrote "a" and dozed off. The nurse said, "Are you writing 'baby'?" and I shook my head yes! She told me that he was healthy, 7lbs 2.5 oz. He had no problems and went straight to the newborn nursery.

They took the breathing tube out and I said, "Is it Friday?" and the nurse said, "No, it is Thursday, 2 in the afternoon!" I was so so happy my baby was OK and I was still here. It was finally over! The worry, the fear, the unknown!

My surgeon came and held my hand and  told me that they did have to do the hysterectomy, the main vein in the placenta had grew very deep into my cervix. They also had to take most of my cervix. I lost 7 ½ liters of blood. I was given 13 units of blood products. 

[kmom note: 7.5 L is 7500 ml. Normal blood loss in a vaginal birth is 500 ml; 1000 in a cesarean. She had more than 7x the normal blood loss for a cesarean.]

I didn't care at that point. I was alive, my baby was healthy! We made it to the other side. PRAISE GOD we were OK!

I met my little man when he was 8 hours old. He is perfect. I would do it all again to have him. We have both done very well recovering physically. I didn't need a bladder bag after all. I delivered on a Thursday and we came home together on Sunday. 

But emotionally it has not been so easy. I do sit here in disbelief sometimes wondering why me? Other days I get angry. I want to punch something and yell GIVE ME MY UTERUS BACK! I mourn the loss of my fertility, the loss of his birth and the first 8 hours of his life. The loss of my last pregnancy. The loss of some relationships that have been damaged through all this for one reason or another.

I share my story not to scare anyone. I know what it feels like to be scared into something. I would never want to do that to someone else. I just want women to be aware of all possible complications. I want women to be able to give true consent and be aware of all risks. 

If sharing my story saves one women from having a different ending than me then it wasn't all for nothing. Accreta is not talked about, but it is real, very real!












Saturday, April 5, 2014

Long-Term Implications of a High Cesarean Rate in Obese Women

April is Cesarean Awareness Month.

This is an annual observance sponsored by the International Cesarean Awareness Network (ICAN) to raise awareness of the implications of a high cesarean rate and lack of access to VBAC (Vaginal Birth After Cesarean).

It's always important to remind readers that this observance is not meant to make anyone feel bad about having had a cesarean, or to imply that having a cesarean makes you "less of a mother" or "less of a woman." Nonsense.

Cesareans can be life-saving and wonderful when used appropriately, but they are not risk-free. When over-utilized, they can have dramatic negative consequences too, especially long-term.

Cesarean Awareness Month is not about any one person's experience at all, but rather about the widespread public health implications of a high cesarean rate and lack of access to VBAC. And this certainly is an under-appreciated public health care issue.

Long-Term Risks of Too Many Cesareans

As we posted about extensively last year, one of the overlooked long-term consequences of a high cesarean rate is an increase in the risk for placental disorders.

Specifically, there is a substantial increase in the risk for:
Here is yet another study that confirms cesarean section as a strong risk factor for placental disorders.

Although this meta-analysis does not evaluate the risk by number of prior cesareans, merely by the presence of prior cesarean, a number of other studies have shown that the risk increases strongly with multiple prior cesareans in a dose-dependent manner.

This is why it is important not to have cesarean after cesarean unless it is medically necessary, and why the ban on VBACs in many hospitals is so frustrating.

The ban on VBAC (Vaginal Birth After Cesarean) in some places means that thousands of women have been and are continuing to be subjected to unnecessary cesareans. This in turn is raising the incidence of placental disorders like previa, abruption, and accreta, as well as maternal morbidity from the surgeries and the very serious complication of cesarean scar pregnancy.

Although with good care, many of these complications can be handled, they do often result in life-threatening hemorrhages, bladder or renal damage, uterine ruptures, hysterectomies, prematurity, stillbirth, and even maternal deaths at times.

Although these complications are overall rare, they are happening to real women, with real results, sometimes devastating ones.

This is why it is SO important to do cesareans only when truly indicated, to avoid automatic repeat cesareans, and to keep VBACs available as an option everywhere.

Implications for Women of Size

Long-term complications of cesareans is a particularly pertinent issue for women of size.

If a 32.8% overall national c-section rate is too high, then the rate in "obese" women is an even GREATER reason for concern because in most studies it starts at 30% and goes as high as 40%50%, 60%, and even 70% in some places and groups.

And many of the cesareans done in obese women are done without any labor at all. Many care providers have a de-facto policy of automatic "elective" cesareans for very obese women, despite the fact that this does not improve outcomes.

This disproportionately exposes the larger mother to the risks of cesareans (hemorrhage, infection, blood clots, bladder injury, and anesthesia problems) and subsequent placental disorders. This is insane. Yet few in the obstetric community even question the high cesarean rate in obese women.

This is why observing Cesarean Awareness Month is so important. It's not about putting down anyone who had a c-section, but to raise awareness of the health implications of a too-high cesarean rate.

In addition, it's time for care providers to focus on the implications of the sky-high cesarean rate in women of size and what can be done to lower that rate.

This is why I always observe Cesarean Awareness Month here and why I urge others to do so too.


References

Cesareans and Subsequent Placental Disorders

J Perinat Med. 2014 Feb 24. pii: /j/jpme-ahead-of-print/jpm-2013-0199/jpm-2013-0199.xml. doi: 10.1515/jpm-2013-0199. [Epub ahead of print] Cesarean section and placental disorders in subsequent pregnancies - a meta-analysis. Klar M, Michels KB. PMID: 24566357
...OBJECTIVE: To examine the association between CS and three major types of placental disorders (placental abruption, placenta previa, and placenta accreta with its variants increta/percreta) in subsequent pregnancies. SEARCH STRATEGY: ...observational studies published between January 1990 and July 2011 for examining the association between CS and placental disorders in subsequent pregnancies, without focusing on the effect of increasing number of CSs... DATA COLLECTION AND ANALYSIS: Five cohort and 11 case-control studies met the inclusion criteria for this meta-analysis...MAIN RESULTS: The calculated summary odds ratio was 1.47 (95% confidence interval, CI: 1.44-1.51) for placenta previa, 1.96 (95% CI: 1.41-2.74) for placenta accreta, and 1.38 (95% CI: 1.35-1.41) for placental abruption. CONCLUSION: In this meta-analysis, cesarean delivery appeared as a consistently reported risk factor for all three major forms of placental disorders in subsequent pregnancies.
Obstet Gynecol Clin North Am. 2013 Mar;40(1):137-54. doi: 10.1016/j.ogc.2012.12.002. Placenta accreta, increta, and percreta. Wortman AC, Alexander JM. PMID: 23466142
Placenta accreta is an abnormal adherence of the placenta to the uterine wall that can lead to significant maternal morbidity and mortality. The incidence of placenta accreta has increased 13-fold since the early 1900s and directly correlates with the increasing cesarean delivery rate...
Placenta. 2012 Apr;33(4):244-51. doi: 10.1016/j.placenta.2011.11.010. Epub 2012 Jan 28. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Jauniaux E, Jurkovic D. PMID: 22284667
...Overall these data support the concept that abnormal decidualization and trophoblastic changes of the placental bed in placenta accreta are secondary to the uterine scar and thus entirely iatrogenic.
Am J Obstet Gynecol. 2011 Dec;205(6 Suppl):S2-10. doi: 10.1016/j.ajog.2011.09.028. Epub 2011 Oct 6. Long-term maternal morbidity associated with repeat cesarean delivery. Clark EA, Silver RM. PMID: 22114995
Concern regarding the association between cesarean delivery and long-term maternal morbidity is growing as the rate of cesarean delivery continues to increase. Observational evidence suggests that the risk of morbidity increases with increasing number of cesarean deliveries. The dominant maternal risk in subsequent pregnancies is placenta accreta spectrum disorder and its associated complications. A history of multiple cesarean deliveries is the major risk factor for this condition. Pregnancies following cesarean delivery also have increased risk for other types of abnormal placentation, reduced fetal growth, preterm birth, and possibly stillbirth. Chronic maternal morbidities associated with cesarean delivery include pelvic pain and adhesions. Adverse reproductive effects may include decreased fertility and increased risk of spontaneous abortion and ectopic pregnancy. Clinicians and patients need to be aware of the long-term risks associated with cesarean delivery so that they can be considered when determining the method of delivery for first and subsequent births.
J Matern Fetal Neonatal Med. 2011 Nov;24(11):1341-6. doi: 10.3109/14767058.2011.553695. Epub 2011 Mar 7. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. Solheim KN1, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. PMID: 21381881
OBJECTIVE: The overall annual incidence rate of caesarean delivery in the United States has been steadily rising since 1996, reaching 32.9% in 2009. Primary cesareans often lead to repeat cesareans, which may lead to placenta previa and placenta accreta. This study's goal was to forecast the effect of rising primary and secondary cesarean rates on annual incidence of placenta previa, placenta accreta, and maternal mortality. METHODS: A decision-analytic model was built using TreeAge Pro software to estimate the future annual incidence of placenta previa, placenta accreta, and maternal mortality using data on national birthing order trends and cesarean and vaginal birth after cesarean rates. Baseline assumptions were derived from the literature, including the likelihood of previa and accreta among women with multiple previous cesarean deliveries. RESULTS: If primary and secondary cesarean rates continue to rise as they have in recent years, by 2020 the cesarean delivery rate will be 56.2%, and there will be an additional 6236 placenta previas, 4504 placenta accretas, and 130 maternal deaths annually. The rise in these complications will lag behind the rise in cesareans by approximately 6 years. CONCLUSIONS: If cesarean rates continue to increase, the annual incidence of placenta previa, placenta accreta, and maternal death will also rise substantially.
Obesity and Over-Utilization of Cesareans

Am J Obstet Gynecol. 2012 May;206(5):417.e1-6. doi: 10.1016/j.ajog.2012.02.037. Epub 2012 Mar 7. Maternal superobesity and perinatal outcomes. Marshall NE1, Guild C, Cheng YW, Caughey AB, Halloran DR. PMID: 22542116
OBJECTIVE: The purpose of this study was to determine the effect of maternal superobesity (body mass index [BMI], ≥ 50 kg/m(2)) compared with morbid obesity (BMI, 40-49.9 kg/m(2)) or obesity (BMI, 30-39.9 kg/m(2)) on perinatal outcomes. STUDY DESIGN: We conducted a retrospective cohort study of birth records that were linked to hospital discharge data for all liveborn singleton term infants who were born to obese Missouri residents from 2000-2006. We excluded major congenital anomalies and women with diabetes mellitus or chronic hypertension. RESULTS: There were 64,272 births that met the study criteria, which included 1185 superobese mothers (1.8%)...Almost one-half of all superobese women (49.1%) delivered by cesarean section, and 33.8% of superobese nulliparous women underwent scheduled primary cesarean delivery. 
BJOG. 2011 Mar;118(4):480-7. doi: 10.1111/j.1471-0528.2010.02832.x. Epub 2011 Jan 18.
Planned vaginal delivery or planned caesarean delivery in women with extreme obesity.
Homer CS1, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. PMID: 21244616
OBJECTIVE: To compare the outcomes of planned vaginal versus planned caesarean delivery in a cohort of extremely obese women (body mass index ≥ 50 kg/m(2)). DESIGN: A national cohort study using the UK Obstetric Surveillance System (UKOSS). SETTING: All hospitals with consultant-led maternity units in the UK. POPULATION: Five hundred and ninety-one extremely obese women delivering in the UK between September 2007 and August 2008...CONCLUSIONS: This study does not provide evidence to support a routine policy of caesarean delivery for extremely obese women on the basis of concern about higher rates of delivery complications, but does support a policy of individualised decision-making on the mode of delivery based on a thorough assessment of potential risk factors for poor delivery outcomes.

Sunday, September 29, 2013

Placenta Accreta, Part Four: Diagnosis, Treatment, and a Cautionary Story

Illustration of placentas (and truncated umbilical cords),
showing the difference between normal and abnormal placental
implantation with differing degrees of accreta; look at the light red
areas where the placenta touches the uterus to see the difference
Image from Wikimedia Commons

We have been talking about abnormal placentation in pregnancies after a cesarean, including:
  • placental abruption (the placenta shearing off before the baby is ready to be born) 
  • placenta previa (a low-lying placenta that covers or nearly covers the cervix)
  • placenta accreta (an abnormally attached placenta that has difficulty detaching after birth)
All of these can be life-threatening to both mother and baby, but placenta accreta is particularly serious.

In Part One of this series, we summarized how the placenta works, what placenta accreta is, and its different levels of severity.

In Part Two of the series, we discussed the risk factors, symptoms, and incidence of placenta accreta, including its strong association with prior cesareans.

In Part Three of the series, we discussed the very serious risks associated with placenta accreta, both to the mother, to the baby, and to future pregnancies (if any).

Today, in Part Four, we will discuss the detection and diagnosis of accretas, the treatment options for accreta, things to be aware of if you are diagnosed with accreta, and share the personal story of someone with accreta.
*Warning: This post contains some graphic photos of accreta surgeries.
Placenta Accreta

In case there are any readers new to the series, let's briefly review the basics of how an abnormally attached placenta (accreta) happens.

In a normal pregnancy, the decidua (lining of the uterus) prevents the placenta from invading the uterine wall. In placenta accreta, the decidua is thin or deficient due to damage or scar tissue from prior cesareans or other uterine instrumentation. This allows the placenta to attach itself directly into the maternal tissues. How deeply the placenta attaches determines the severity of the accreta.

image from fetalsono.com 

In Placenta Accreta, the placenta forms an abnormal attachment to the wall of the uterus. About 75% of accretas are in this form.

In Placenta Increta, the placenta actually grows deeply into the muscle of the uterus (myometrium).

In Placenta Percreta, the placenta grows through the muscle of the uterus, through the outer layer, and often into adjacent structures nearby, like the bladder or bowels.

Fortunately, foreknowledge of an accreta, careful management protocols, and being in the right delivery setting can significantly lower the risk for mortality and morbidity.

Detection and Diagnosis of Accreta

As mentioned in Part Two of this series, bleeding after the first trimester is the most common symptom of placenta accreta.

If you experience bleeding after the first trimester or significant abdominal pain, this should be promptly investigated with a targeted ultrasound.

But what if you've had cesareans (or have other risk factors) and are now in a new pregnancy? Should you have an automatic ultrasound for placental placement, whether or not you have symptoms?

To Screen or Not to Screen?

Screening a woman with symptoms is a no-brainer. The benefits of confirming or ruling out an accreta far outweigh any potential risk for someone already presenting with possible symptoms.

A harder decision is whether to automatically screen all non-symptomatic women simply because they have risk factors like a prior cesarean, a history of infertility treatment, fibroid removals, or a D&C.

Remember, all prenatal testing ─ including ultrasound ─ has pros and cons. Although it can discover many complications ahead of time that may result in life-saving treatment, there is also a high rate of false-positives that can lead to panic and overtreatment. Furthermore, research has not shown that routine ultrasound screening in pregnancy improves outcomes.

On the other hand, selected screening in special situations can improve outcomes.  The question is whether women who are not symptomatic but who simply have risk factors for accreta fall into this category.

Bottom line, there are no clear answers. This is a judgment call.

Accreta is a rare condition, even in women with risk factors, so chances are that most women without symptoms would be okay without doing a routine screening since accretas usually present with symptoms before term.

On the other hand, there are cases where women are asymptomatic before delivery but do have an accreta and experience significant difficulties during the birth.  And research shows that outcomes do tend to improve if the condition is known about ahead of time so special plans can be made.

Because placenta accreta is such a serious complication, many care providers feel it is prudent to at have an ultrasound for placental placement at some point if you have risk factors for accreta (like a prior cesarean). 

The more risk factors you have (i.e. multiple prior cesareans, several prior D&Cs, prior cesarean plus an IVF pregnancy etc.), the more important a screening ultrasound probably is.

Of course, you may decide that the cons of prenatal ultrasound are outweighed by its benefits in finding a possible accreta or other issues. It is always your option to decline any form of prenatal testing, but in making your decision, you do need to weigh the increased risk for abnormal placentation after a prior cesarean and the fact that detection of this condition before birth may help improve outcomes.

The consensus among most providers seems to be that the more cesareans or other uterine procedures you have had, the more consideration should be given to an ultrasound for placental placement ─ but again, the choice is always yours.

Timing

If you do decide on testing, don't do a placental placement ultrasound too early, since placentas often "move up" during pregnancy as the uterus expands.

What looks like a potential problem early in pregnancy often resolves itself fully by later pregnancy, so there's no need to raise anxiety levels by doing one in the first trimester.

Most providers feel that a screening ultrasound in the second or early third trimester is early enough if there are no other symptoms suggestive of a previa or accreta. On the other hand, if significant bleeding occurs or there is significant abdominal pain, that can be an early sign of severe placental issues, and an earlier ultrasound then becomes more sensible.

If you choose to do the standard ultrasound for birth defects at 18-20 weeks, they can check for placental placement then. Otherwise, if there are no symptoms, many providers are fine with waiting until the late second trimester or early third trimester to check for placental placement.

If in doubt, discuss the pros and cons of your unique situation with your provider and then make your decision.

What They Look For

If you do develop placenta accreta, it's important to know as much about it ahead of time as possible.

A targeted ultrasound usually shows what's needed. This is simply a regular ultrasound that lasts a little longer than usual and is specifically looking closely for certain issues (in this case, placentation). In some cases, a follow-up transvaginal ultrasound may also help clarify the diagnosis or rule it out.

According to ACOG (the American Congress of Obstetricians and Gynecologists), the following signs may indicate a possible accreta:
The ultrasonographic features suggestive of placenta accreta include irregularly shaped placental lacunae (vascular spaces) within the placenta, thinning of the myometrium overlying the placenta, loss of the retroplacental “clear space,” protrusion of the placenta into the bladder, increased vascularity of the uterine serosa–bladder interface, and turbulent blood flow through the lacunae on Doppler ultrasonography. The presence and increasing number of lacunae within the placenta at 15–20 weeks of gestation have been shown to be the most predictive ultrasonographic signs of placenta accreta, with a sensitivity of 79% and a positive predictive value of 92%. These lacunae may result in the placenta having a “moth-eaten” or “Swiss cheese” appearance.
If in doubt, don't be afraid to request a second opinion or another scan. If accreta is suspected, ask for a consult with a specialist associated with a center that does a lot of prenatal testing. These are the people with the most sophisticated equipment and greatest expertise in trying to detect whether or not there is a problem.

Additional Technology

MRI image of possible percreta in patient with 2 prior D&Cs
"P" marks placenta previa (low-lying, below head)
arrows point to possible bladder involvement
Image from Ochsner 2011
Although regular "grayscale" ultrasounds are usually sufficient for diagnosis of most accretas, color Doppler, 3D ultrasound, or an MRI can sometimes be helpful to identify the degree of placental invasion.

MRIs may be particularly helpful if there is a posterior placenta (on the back of the uterus), if the ultrasound findings are ambiguous, or if a percreta with bladder involvement is suspected. Some resources also recommend an MRI for placental placement in women with "morbid obesity" and accreta risk factors if there is any difficulty getting a clear image with ultrasound alone.

Color Doppler, 3D ultrasound, and MRIs are not considered standard of care at this point and are not routinely done, even when an accreta is suspected. However, they can be useful adjunct tools to clarify the degree of accreta or to assist when ultrasound findings are inconclusive. Don't be hesitant to ask about this possibility if you feel the results are ambiguous at all.

Sometimes the diagnosis of accreta is less than definitive, especially with milder accretas. Since absolute confirmation of a diagnosis is always done in hindsight and needs lab analysis of both the placenta and the uterus (which would only happen after a hysterectomy), accreta diagnosis is most often based on physicians' opinion of test findings and their clinical impression of the situation.

This means that while obvious cases are usually caught, milder cases may not always be apparent until problems crop up during birth. It also means that sometimes a false positive diagnosis (thinking there's an accreta when there's really not) can occur.

So if in doubt, further testing with additional technology may help clarify ambiguous results.

Treatment of Accreta

Placenta Percreta - notice how the placenta is growing into the uterus
Image from Tikkanen 2011, J Med Case Rep
In Part Three of this series, we discussed the risks of placenta accreta.  Bottom line, the biggest risk with accretas is severe bleeding because the placenta cannot detach properly at birth.

In the short term, this can require multiple blood transfusions, cause a life-threatening blood clotting crisis, or necessitate a hysterectomy.

In the long term, it can cause postpartum anemia, difficulty breastfeeding, or even Sheehan's Syndrome (damage to the mother's pituitary gland, resulting in long-term health problems).

Since major blood loss is the biggest risk of an accreta and it is difficult to predict who is most at risk of severe blood loss, treatment of accretas usually revolves around trying to proactively prevent as much blood loss as possible.

To Remove the Placenta or Not to Remove the Placenta?

Trying to forcibly remove a stuck placenta is the strongest predictor for severe bleeding and other complications. Therefore, much of the treatment of placenta accreta involves avoiding removing the placenta at all.

Sometimes, in cases with very minor accretas, the placenta can be separated from the uterus with a little time and patience or the help of Dilation and Curettage (D&C).  However, most of the time, a manual removal or a D&C is the last thing you want to try with accreta because it is often the beginning of major complications.

Because any attempt to deliver the placenta in a significant accreta can cause torrential bleeding, optimal treatment in these cases usually means leaving the placenta in place ("in situ") instead of trying to cut it out. The question is what to do with the placenta then.

Most OBs consider the standard of care for accreta to be a cesarean hysterectomy. After the baby is delivered, they leave the placenta intact in the uterus and then just take out the uterus with the placenta still attached, as can be seen here. This approach is widely regarded as having the best outcomes in research studies.

For women who desperately want another pregnancy and who are not bleeding too severely, other approaches are possible, although research is still being gathered on their feasibility and safety.

In the Expectant Management approach, doctors can deliver the baby, leave the placenta in place, suture the mother back up, and then wait for the body to break down and re-absorb the placenta. Alternatively, a late hysterectomy can be performed in a few weeks after the placenta has begun to break down and the risk of bleeding has diminished somewhat.

placenta percreta left in situ
methotrexate administered, hysterectomy 7 weeks later
Image from Tikkanen 2011, J Med Case Rep
In the Medical Management approach, they do the same thing but also administer strong drugs like methotrexate to help break down the placenta. However, methotrexate is considered a contraindication to breastfeeding, and its efficacy is disputed.

The Expectant or Medical Management processes take months (and must be carefully monitored with follow-up ultrasounds, serial HCG measurements, and other tests), but can be effective. With this approach, some women are able to preserve their uterus, and a few women have gone on to have other children afterwards.

However, these approaches have significant risks. Sometimes the woman develops an infection from the leftover tissue, or can't stop hemorrhaging internally. Often additional procedures are needed to address an infection, bleeding, or blood clots. In a number of cases, a late hysterectomy is still needed (as in the picture above). In rare cases, women have been known to die from leaving the placenta and uterus in place.

Another possibility is Conservative Surgical Management. In this approach, doctors surgically resect the uterus when relatively minor degrees of accreta are present. Resection involves cutting out the part of the uterus with the implanted placenta, then suturing the sides of the uterus back together. There are a few case reports of this technique being used successfully, and even of pregnancy afterwards.

Yet another option is Uterine Arterial Embolization (UAE) ─ trying to deliberately cause a blood clot by injecting small particles into the arteries around the uterus in order to minimize bleeding. Without as much of its blood supply, the placenta then theoretically reabsorbs into the body more quickly. In one very small study, about 2/3 of the women who had UAE had successful outcomes, although there was a higher rate of secondary complications and longer hospitalizations. Other studies have also found good rates of success, although accompanied by significant complications at times.  Some case reports even note successful term pregnancies after UAE.

These alternative treatments remain controversial. Research into them is evolving but the current consensus opinion from ACOG is that a cesarean hysterectomy is the best course of action:
[The alternative management] approach should be considered only when the patient has a strong desire for future fertility as well as hemodynamic stability, normal coagulation status, and is willing to accept the risks involved in this conservative approach. The patient should be counseled that the outcome of this approach is unpredictable and that there is an increased risk of significant complications as well as the need for later hysterectomy. Reported cases of subsequent successful pregnancy in patients treated with this approach are rare. This approach should be abandoned and hysterectomy performed if excessive bleeding is noted...Except in specific cases, hysterectomy remains the treatment of choice for patients with placenta accreta.
So while uterus-conserving treatment is possible and there is a fair amount of excited research on the possibility, the trials have been relatively small so far and outcomes have been mixed. Experts at this point definitely favor a cesarean hysterectomy in most cases.

However, if a mother strongly desires to preserve her fertility and is not experiencing severe bleeding, uterine-conserving approaches can be considered as long as the mother fully understands and accepts the possible risks. She should also understand that even if another pregnancy occurs, there is a substantial risk of another accreta as well.

If You Develop Placenta Accreta

Being told you might have placenta accreta is scary.  Decisions can seem overwhelming and information for making them may be sparse.

This section is to help you understand the probable choices around your birth and why many procedures are used. Of course, each woman's situation is different and differences in circumstances may mean that your optimal treatment can be different from someone else's optimal treatment.

You should know that because accreta has been so rare in the past, there are no randomized trials to determine the most effective course of treatment. This means that no one is completely sure of the best way to handle an accreta.  Therefore, it's vital that you understand your choices and discuss the pros and cons of each carefully with your provider.

No medical advice should be inferred from this information; it is provided simply to suggest things to discuss with your providers as you consider your choices. You should do your own research and consult your providers closely as you contemplate your options.

First, Don't Panic

Being diagnosed with placenta accreta can be very frightening. Research summaries often emphasize worst-possible outcomes. Support groups, while valuable, can have scary stories of complications and problems. Even this post has to emphasize the risks so that women fully understand the possibilities, but that doesn't mean they will happen to you.

Remember, while it's important to be aware of the significant risks of accreta, it's also important to keep the risks in perspective.

Most women with accretas have reasonably good outcomes.  And knowing about the accreta ahead of time has been shown to significantly improve outcomes and minimize morbidity in many cases.

So while there is reason to be concerned and women should spend time educating themselves about this condition, it's also important to keep the risks in perspective and know that chances are strong that you and your baby will be okay. If you start to get overwhelmed, take a deep breath and keep reminding yourself of this fact.

Reach out to other moms who have been through accreta or other complicated pregnancies and get some support from people who really "get" what you are going through. In them, you may find your biggest source of sanity and courage.

Where to Deliver and Who Should Be There

Accretas make for complicated surgeries, but they are fairly rare surgeries. Because they don't happen very often, you want an expert who is experienced in dealing with them. Therefore, your local care provider should refer you to a team of maternal-fetal medicine specialists at a large hospital in your area. Research shows improved outcomes when accretas are delivered by multidisciplinary specialist teams instead of standard obstetric care.

Delivery should not take place in your local community hospital, but rather in a regional or specialist ("tertiary") hospital with access to significant blood reserves and an established protocol for severe hemorrhage. This offers you the best chance at a good outcome.

ACOG recommends consulting with specialists ahead of time and having as many on call during the surgery as possible:
Delivery planning may involve an anesthesiologist, obstetrician, pelvic surgeon such as a gynecologic oncologist, intensivist, maternal–fetal medicine specialist, neonatologist, urologist, hematologist, and interventional radiologist to optimize the patient’s outcome. To enhance patient safety, it is important that the delivery be performed by an experienced obstetric team that includes an obstetric surgeon, with other surgical specialists, such as urologists, general surgeons, and gynecologic oncologists, available if necessary.
These specialists are to cover any possible severe complications that lie beyond the normal scope of training for most OBs. For example, if difficulty with blood clotting develops, a hematologist may need to be called in. If the baby is very premature, a neonatologist may be needed. If there is a percreta that has invaded nearby organs, a urologist, general surgeon, or gynecologic oncologist may be needed. An interventional radiologist may be utilized if they decide to use UAE (see above).

Hopefully, you will not need any of these specialists, but the idea is to have a strong plan ahead of time and to have consultants on call in case complications occur. Most will never be called upon, but it's best to have them ready just in case.

When and How to Deliver

There are many aspects unique to delivering an accreta pregnancy. Here are a few to discuss with your care provider.

Planned Cesareans
 
Image from singhealth.com.sg
If a significant accreta is present, you will likely need to deliver via a planned cesarean section.

Very minor or questionable accretas can sometimes have a vaginal delivery, then wait and see if spontaneous placental separation occurs, but even minor accretas can still result in significant hemorrhage and complications that necessitate a cesarean or hysterectomy, so most providers prefer a planned cesarean.

Since emergency cesareans have poorer outcomes with accretas, there is a strong case to be made that a planned cesarean is the best choice in order to have the necessary specialists standing by and plenty of blood products on hand if needed. Of course, much will depend on the degree of accreta that is expected, but most experts feel that known accretas are best delivered by cesarean.

Prematurity

Most accreta pregnancies deliver before full-term, adding the complications of prematurity to the many other issues associated with accreta. This means more challenges with learning to nurse, difficulties in sustaining body temperature and blood sugar, and possible issues with brain bleeds, vision issues, infections, and other problems.

Many preemies do amazingly well these days, but dealing with a preemie can be an emotional rollercoaster. The family involved needs to start educating itself about prematurity issues and lining up support in case the baby does arrive early. A few resources on prematurity are listed below in the Resources Section, but a quick internet search will bring up many more.

Prenatal Hospitalization

If you have been experiencing intermittent significant bleeding episodes or have bled before 32 weeks, your care providers will quite likely want you hospitalized for some time before the scheduled delivery, since these cases are more at risk for emergency delivery and this is best handled with immediately available resources.

Even if you are not having major prenatal bleeds, you and your provider need to be ready for an emergency delivery in case one suddenly becomes necessary. Therefore, if you do not live near the tertiary hospital where you will deliver, your specialists may recommend that you be hospitalized before the birth or that you take a temporary apartment very close by. At the very least, you should have a plan for childcare for any older children and a packed bag ready to go should you suddenly need to be hospitalized.

Being put on bedrest or confined to the hospital for weeks ahead of the birth can be very stressful. Emotional support from groups like Sidelines National Support Group can be invaluable if you experience this.

Timing of Delivery

If there is no need for an early emergency delivery, most resources recommend delivery between 34 and 36 weeks when accreta is present. This timing seems to offer the best balance between awaiting fetal maturity yet avoiding significant hemorrhage, since one study found that more than 90% of their patients with accreta experienced a significant bleed after about 35 weeks. Some doctors will agree to wait a bit longer, depending on the circumstances, but most agree the baby should be delivered before term.

One important question is fetal lung maturity before delivery.  If a very early delivery looks likely, then a prenatal course of steroids may be administered in hopes that this will help the baby's lungs to mature before delivery must occur.  The OB then needs to decide whether or not to do an amniocentesis before delivery to confirm fetal lung maturity.

If the pregnancy makes it to the usual delivery time of 34-36 weeks, an amnio is more questionable. Current opinion is that doing an amnio does not seem to improve outcome, but many doctors prefer to err on the side of caution and do one anyway.

ACOG's accreta guidelines suggest individualizing the timing of delivery, depending on each person's circumstances:
The timing of delivery in cases of suspected placenta accreta must be individualized. This decision should be made jointly with the patient, obstetrician, and neonatologist...A guiding principle in management is to achieve a planned delivery because data suggest greater blood loss and complications in emergent cesarean hysterectomy versus planned cesarean hysterectomy. Although a planned delivery is the goal, a contingency plan for emergency delivery should be developed for each patient, which may include following an institutional protocol for maternal hemorrhage management. 
The timing of delivery should be individualized, depending on patient circumstances and preferences. One option is to perform delivery after fetal pulmonary maturity has been demonstrated by amniocentesis. However, the results of a recent decision analysis suggested that combined maternal and neonatal outcomes are optimized in stable patients with delivery at 34 weeks of gestation without amniocentesis. The decision to administer antenatal corticosteroids and the timing of administration should be individualized.
Surgical Details and Preparation
 
highly vascular lower uterine segment, suggesting placental
implantation in the area where an incision would normally be made
Image from Cheung and Chan, 2012
The type of incision used is left up to the individual doctor, based on the circumstances of the case.

Most resources strongly recommend against cutting into the placenta at all. This will help minimize bleeding.

If the placenta is low-lying (placenta previa with accreta) or covers most of the anterior wall, doctors may decide to use a vertical (up-down) instead of the usual low horizontal side-to-side incision.

placenta percreta, bladder involvement
Image from AJOG 2010
Sometimes the uterus is taken out entirely to facilitate an incision away from an anterior accreta.

In the photo to the left, the uterus has been taken out so the doctors can do a fundal (top of uterus) and posterior (on the back side of the uterus) incision in order to keep the placenta and its bladder invasion intact before the hysterectomy.

During the surgery, some doctors have the mother's legs placed in special stirrups. This might seem strange for a cesarean delivery, but it is a precaution so that both vaginal and abdominal packing can be placed if bleeding is significant.

Antibiotics will be administered just before or right as the surgery is started. Because of the increased risk for infection, accreta patients may also receive additional doses after the surgery, if surgery is prolonged, or if uterus-conserving techniques are chosen. If you are a woman of size, don't forget to discuss the possibility of weight-based antibiotic dosing or extended dosing with your doctor in order to minimize your risk for infection. Post-operatively, probiotics may help promote gut health if you experience gastrointestinal problems from the antibiotics.

Preparing for Blood Loss

Because maternal blood loss is one of the biggest risks associated with accretas, ACOG recommends having strong maternal hemoglobin levels in advance of the surgery.

This can be done with iron pills, with herbal preparations (like Floradix, alfalfa, dandelion roots, nettle leaves, beet roots, etc.), or with food (like red meat, dark meat chicken, eggs, cashews, lentils, molasses, dried fruit, seaweed, leafy greens, pumpkin seeds, etc.). Take iron-rich foods with vitamin C, as this increases absorption strongly. Supplementation with Vitamin B-6 may also be helpful. On the other hand, don't take iron pills or foods with dairy products, caffeine, or antacids, as these inhibit absorption.

Your blood should be typed and matched before surgery, and blood products should be readily available in the O.R. during surgery. The blood blank should also be on call to provide additional units quickly if needed. In some areas, they may also be asked to stock certain additives that may also help if a severe hemorrhage occurs.

ACOG also recommends considering having a way to salvage the mother's own blood loss and return it to her during the surgery.
Because of the risk of massive blood loss, attention should be paid to maternal hemoglobin levels in advance of surgery, if possible. Many patients with placenta accreta require emergency preterm delivery because of the sudden onset of massive hemorrhage. Autologous blood salvage devices have proved safe, and the use of these devices may be a valuable adjunct during the surgery.
Sometimes, donating blood ahead of time for yourself is possible, as is using a donation from an adult family member with the same blood type. This is not always possible or optimal, but you can certainly ask your doctor about the possibility. It is not standard protocol at this time, however.

You are quite likely to need a blood transfusion at some point in your recovery if you have a significant accreta. Many women require multiple transfusions. Be prepared for this issue, and for the strong likelihood of hysterectomy if bleeding is not able to be controlled.

Anesthesia

The best anesthesia choice for accreta patients is still debated.

Many OBs strongly prefer general anesthesia. This offers the advantage of an unlimited amount of surgery time (in case the surgery is complicated).  It also keeps the patient unconscious during what may be a difficult and scary surgery (most percretas are done with general anesthesia, for example). The biggest disadvantage of a general is that it tends to affect the baby negatively, and doesn't provide very good post-op pain relief.

Some OBs are fine with regional anesthesia (spinal, epidural, or combined spinal-epidural [CSE]). This allows the mother to be conscious for the baby's birth, improves fetal Apgar scores, and tends to offer better post-partum pain control as well. However, most regional anesthesia (except CSE) will not last long enough if surgery becomes prolonged. In addition, most surgeons don't want the patient awake if the surgery gets complicated or if massive hemorrhage occurs.

Some OBs will allow a combination of anesthesia choices when circumstances allow. The mother may start with a spinal or epidural so she can be awake for the baby's birth and so that the baby has minimal exposure to the strong drugs of general anesthesia. Once the baby is delivered and the surgeons have evaluated placental attachment, they may stay with regional anesthesia or opt to convert to general anesthesia so it will work for as long as needed and so that the patient is not awake in case major complications occur.

An anesthesia consult ahead of delivery is very important. You and your care providers should discuss the pros and cons of various approaches, your preferences, and the unique circumstances of your condition that may affect anesthesia choice.

Pre-Operative Precautions

Before a planned cesarean, there are several routine precautions often employed to help improve outcome.

Many providers recommend a special skin preparation routine the day before or the day of the cesarean. This may help reduce the risk for infection, although evidence is not yet clear on the best protocol for skin preparation.

Intravenous access (I.V.) is always placed before any surgery, but your doctors will probably recommend that you have large-bore IV lines or an arterial IV line placed before surgery. This allows a large volume of fluids or blood products to be delivered more quickly in case of hemorrhage.

Many hospitals now use pneumatic compression stockings for all surgical patients. These inflate and deflate on the legs to lower the risk for the development of blood clots that could travel to the lungs. If the standard size does not fit, there are usually pneumatic compression devices that can be used instead of compression stockings. These should be placed before the operation and stay in use until the patient is walking regularly afterwards.

In addition to these procedures, some doctors choose to place a stent (small tube) or catheters in the ureters before a cesarean hysterectomy, which may lessen the risk for damage to the ureters. Again, research is ongoing into this procedure.

Additional Blood Loss Treatment Options

placing arterial catheters (C) and
ureteral catheters (U) pre-operatively
E is the external fetal monitor
Image from Ochsner 2011
Doctors may choose to use additional precautions against severe bleeding and abdominal organ damage, but these options are more controversial.  Research is ongoing into their benefits and risks.

Some OBs place an internal balloon catheter pre-operatively in the arteries around the uterus so that if severe bleeding does occur, they can inflate the balloon to try and shut down the bleeding. A recent literature review of this procedure found conflicting results and recommended further research.

Doctors can also clamp off the uterine arteries in order to reduce the amount of bleeding during the cesarean. This may not be effective because there are many alternative sources of blood supply to this area, but it is another tool in the arsenal that doctors can consider.

Another option is the afore-mentioned Uterine Artery Embolization (UAE). While UAE is usually done in non-pregnant women to treat fibroids, it can also help lessen bleeding with an accreta, either during a hysterectomy or post-operatively. And, as previously mentioned, it may also be tried in a uterus-conserving management of accreta.

It should be noted that all of these additional procedures are still controversial.  ACOG notes:
Current evidence is insufficient to make a firm recommendation on the use of balloon catheter occlusion or embolization to reduce blood loss and improve surgical outcome, but individual situations may warrant their use. Despite initial enthusiasm about the utility of balloon catheter occlusion, available data are unclear regarding its efficacy. Although some investigators have reported reduced blood loss, there have been other reports of no benefits and even of significant complications.
Bottom line, no one is sure whether these procedures help more than they harm.  Research is ongoing.

Birth Plan

Accreta can have such variable outcomes that it is important to have a plan in place for various potential outcomes. This can help guide your doctors about your wishes if you are not available to consult right away.

Things you might want to consider putting into your plan include guidelines for infant feeding, kangaroo care for your partner, preferences regarding newborn procedures and vaccinations, etc. You might also want to consider requesting milk from a human milk donor bank until you are able to produce your own (which might be delayed due to blood loss or placental fragments left inside).

After the Delivery

You will probably be in the hospital for a longer recovery time than most cesarean mothers. You may experience significant abdominal pain afterwards (more than the normal cesarean pain) because of internal bleeding and the surgical trauma of a difficult operation. Wound healing may be somewhat delayed as your body tries to cope with the demands of such a significant challenge to the system.

One Australian study found that about half of women with accreta developed some sort of surgical complication (usually bladder injury), and about 20% needed to have additional surgical procedures later on. If you develop blood in your urine, this should be evaluated right away. In addition, hidden bleeding and infection may develop afterwards, so be sure to get prompt attention if you start to feel more unwell than usual.

It is very important to support your body nutritionally to help it recover from significant blood loss.   Plan on getting plenty of B vitamins and iron after the birth in order to help rebuild your blood supply. Drink plenty of water. Nuts, leafy greens, dried fruit, and red meat are good natural sources of iron, folate, other B vitamins, and the A vitamins so vital to healing.

Long-term, you should be tested several times for postpartum anemia. The majority of women with accreta suffer a quite significant blood loss and this can cause long-lasting anemia. Although many care providers are aware of this, it sometimes gets overlooked as a "minor" concern once the life-threatening crisis is over, and follow-up testing can be neglected. Yet it is a critical quality-of-life issue for your healing and long-term recovery, so don't be hesitant to be assertive about having your levels checked.

Remember that hemorrhage, retained placenta, and anemia can also all negatively negatively impact milk supply, and prematurity can make it difficult for babies to latch on efficiently. Although some women in this situation are able to make breastfeeding work without problems, don't hesitate to consult an IBCLC (Internationally Board-Certified Lactation Consultant) for help if needed.

In time, adequate milk supply may develop with regular pumping, but in the meantime, you may need to supplement with donated human milk or formula while proactively promoting milk supply (see http://www.lowmilksupply.org/). Information about supplementation can be found here. And a great resource for unbiased, non-judgmental support for mothers struggling with breastfeeding difficulties can be found here.

If you experienced a very severe hemorrhage during delivery, be aware that this can sometimes damage your pituitary gland (Sheehan's Syndrome). Thyroid issues, fatigue, body hair loss, and adrenal issues are common long-term complications. If you cannot breastfeed and the return of your period is delayed or quite irregular, ask to be for tested for Sheehan's Syndrome. Also be aware that this complication sometimes doesn't show up until years later, so you may need to be retested several times over the years.

Be sure to plan for a longer recovery time and extra help after the delivery, since recovery is likely to be harder after an accreta.  Don't rush your recovery, but take plenty of time to rest and let your body heal slowly. Sleep, good nutrition, and taking your recovery slowly are your best allies in this.

Having a baby is hard enough on the body; dealing with an accreta and blood loss on top of that is even harder.  Get extra help around the house (a postpartum doula may be helpful) and be sure to accept the help of friends, extended family, and neighbors as much as circumstances allow. Your job is simply to heal and to take care of the baby. Let your partner and others step up to take care of everything else.

Summary

Placenta Accreta is a rare but very serious complication that is associated with prior uterine instrumentation procedures. Although it can occur after a number of different procedures, it is most strongly associated with prior cesarean.  It is most common with rising numbers of prior cesareans, but can occur even in women with only one prior cesarean.

Accretas come in three different levels of severity, but make no mistake, all are potentially life-threatening. Although minor degrees of accreta can often be resolved without major repercussions, the potential for serious complications is always there and must be taken seriously. And the potential complications with the most severe forms are sobering indeed.

Of course, it's only fair to point out that even though the risk for abnormal placentation rises with each cesarean, most women with prior cesareans do not experience placenta previa or accreta. And most cesareans go well, even higher-order cesareans.  So if you have had cesareans before, don't panic. Chances are you'll be okay.

However, from a public health point of view, the take-home message is that risks start rising rapidly as the total number of cesareans increase.

Complications like previa and accreta are more common after three to four or more cesareans. However, sometimes these complications happen when a woman has "only" had one or two prior cesareans. Just because you've only had one or two cesareans instead of four doesn't mean you aren't at risk. It all depends on how well your uterus was able to repair itself and exactly where an embryo implants.

And although the absolute risk for previa and accreta overall is low, it's far higher than it is in women who have never had any cesareans.

Don't forget, sometimes there are babies and women who die from placenta accreta/percreta, or have very near misses.

At the very least, it often results in severe hemorrhage, hysterectomy, loss of fertility, uterine rupture, and significant damage to the urological system or abdomen of the mother, not to mention prematurity in the baby.

This is why it is important to avoid the first cesarean whenever possible, to not automatically schedule repeat cesareans in most women, and to make sure that VBAC stays an option for as many women as possible.

Unfortunately, this is the exact opposite of what's happening in many places right now. And that's why the world will continue to see a strong rise in the number of women experiencing placenta accreta and all its complications.  As one recent study concluded:
If primary and secondary cesarean rates continue to rise as they have in recent years, by 2020 the cesarean delivery rate will be 56.2%, and there will be an additional 6236 placenta previas, 4504 placenta accretas, and 130 maternal deaths annually...If cesarean rates continue to increase, the annual incidence of placenta previa, placenta accreta, and maternal death will also rise substantially.
A Concluding Story

This topic is on my mind because an online friend of mine recently faced placenta accreta. She has given me permission to share her story.

She had an excellent OB and surgical team, her accreta didn't look too severe, and she had her surgery at a very good hospital. But she knew that there were no guarantees, that sometimes an accreta that doesn't look major turns out to be more serious. She was uneasy after reading the story of the mother in Utah who died recently due to placenta accreta and worried about leaving her other children behind.

In the end, I'm happy to report that she had an overall "good" outcome.  They were able to hold off the cesarean until almost term, so baby was not very premature at all.  The mom didn't need to have emergency surgery; they were able to hold off until a very extensive team of surgeons and specialists were standing by, ready to intervene if needed.

Sadly, though, her accreta was severe enough that they did have to do a hysterectomy. Now this mother has lost her uterus and any chance at future children.  She also suffered a lot of blood loss, including internal bleeding after the cesarean that left her with a lot of fatigue and very serious and long-lasting pain.

What's so frustrating is that this might have been preventable. Mismanagement by care providers in pregnancies previous to this one led her down this path and that she is angry about.

She is a woman of size who followed the common birth trajectory of many heavier women ─ pressured into an induction because of her providers' fears about postdates and big baby. Like so many in that situation, she ended with a c-section for "failure to progress" with a malpositioned baby. Like about twelve to thirty percent of big moms, she developed an infection and had a rough recovery.

She was promised that she could pursue a VBAC but was given the old bait-and-switch routine at the end of her second pregnancy.  Many care providers tell high-BMI women they can have a VBAC and then find some reason at the end why they shouldn't have one after all. They pressured her into a repeat cesarean because they told her she was overdue (she wasn't) and because they feared a big baby (baby was 7 lbs.).  So she ended up with a totally unnecessary 2nd c-section.

She planned a VBA2C in her third pregnancy. She did labor this time, but ended up with another cesarean after manipulation by her caregivers. Her cesarean scar re-opened postpartum, she ended up back in the hospital, and the scar took 4 months to heal.  She experienced severe postpartum depression and PTSD.

She planned a VBA3C with her next pregnancy, and was fortunate to have an understanding OB who was supportive. However, due to massive scar tissue in the area, she felt like she needed to have the repeat cesarean in the end. She just had a gut feeling it was the most prudent thing to do with so much scar tissue. Her OB was able to help clean up all the considerable adhesions inside when he did her fourth cesarean, and she was able to avoid the infections and difficulties that had accompanied her earlier cesareans. It was hard because it wasn't the outcome she wanted, but she did feel it was the most prudent choice under her circumstances.

She spent a lot of time getting in shape for her next pregnancy, hoping to be able to go for a VBA4C, only to find out early in the pregnancy that she had both placenta previa and placenta accreta, an ominous finding for someone with multiple prior cesareans. Gone was the hope for a VBAC; now the focus was on making sure she and baby would survive.

In the end, she did lose her uterus and could have lost her baby and her life....all because her past caregivers pushed her down the path of over-intervention and into all those cesareans due to her weight.

THIS is why I fight so hard against a too-high cesarean rate, and in particular against the astronomically high cesarean rate in high-BMI women.

Remember, a high cesarean rate in high-BMI women doesn't start in the operating room. It starts with the high rate of interventions in the women of size, especially the astronomically high induction rate.

A few researchers are beginning to catch on to this.  In one study, the authors point out:
We can conclude that a morbidly obese woman in spontaneous labour has a 70% chance of achieving a vaginal delivery but this falls to only 48% if labour is induced...Management of morbidly obese women with a singleton pregnancy should aim for vaginal delivery and await spontaneous onset of labour.
A high induction rate, a failure to be patient during labor, exaggerated fears about vaginal birth in women of size, and a low threshold for surgical intervention are the engines driving the high cesarean rate in obese women. And this in turn drives the higher rate of poor outcomes among women of size, including fetal distress, wound infections, and now placental complications.

If 50% (or more in some studies) of obese women are ending up with cesareans, then it is only logical that many will develop placenta previa and/or accreta as a result.

Very high cesarean rates and lack of access to VBAC disproportionately expose obese women to the risk of serious morbidity and even mortality with cesareans and abnormal placentation; this MUST stop.

Lives are depending on it.


Research References
 
Accreta Information
Stories of Accreta Moms (not for those trying to gestate in peace!)
Preemie Resources
Emotional Support For Complicated Pregnancies
Breastfeeding Resources
Increase in Incidence of Abnormal Placentation

Obstet Gynecol Clin North Am. 2013 Mar;40(1):137-54. doi: 10.1016/j.ogc.2012.12.002. Placenta accreta, increta, and percreta. Wortman AC, Alexander JM.  PMID: 23466142
Placenta accreta is an abnormal adherence of the placenta to the uterine wall that can lead to significant maternal morbidity and mortality. The incidence of placenta accreta has increased 13-fold since the early 1900s and directly correlates with the increasing cesarean delivery rate. The prenatal diagnosis of placenta accreta by ultrasound along with risk factors including placenta previa and prior cesarean delivery can aid in delivery planning and improved outcomes. Referral to a tertiary care center and the use of a multidisciplinary care team is recommended.
Aust N Z J Obstet Gynaecol. 2004 Jun;44(3):210-3. Is placenta accreta catching up with us? Armstrong CA, Harding S, Matthews T, Dickinson JE. PMID: 15191444
...METHODS: A retrospective review of all cases of placenta accreta and variants during the period of 1998-2002...RESULTS: ...Seventy-eight percent of cases had had at least one prior Caesarean birth, and 88% of cases were associated with placenta praevia. ...Hysterectomy was performed in 91% of cases with median intraoperative blood loss of 3000 mL. There were no maternal deaths in the current series. CONCLUSION: A strong association between placenta accreta, placenta praevia and prior Caesarean birth has been demonstrated... 
Treatment of Placenta Accreta

Acta Obstet Gynecol Scand. 2011 Oct;90(10):1140-6. doi: 10.1111/j.1600-0412.2011.01147.x. Epub 2011 May 25. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. PMID: 21488840
POPULATION: Twenty-four women with placenta accreta diagnosed antenatally and 20 women discovered intrapartum. ...CONCLUSIONS: Antenatal diagnosis of placenta accreta may reduce peripartum blood loss and the need for blood transfusion. Women with antenatal diagnosis more often have placenta previa and history of previous cesarean section, and the clinical diagnosis is more often placenta percreta.
Int J Womens Health. 2012;4:587-94. doi: 10.2147/IJWH.S28853. Epub 2012 Nov 26. The sonographic appearance and obstetric management of placenta accreta. Cheung CS, Chan BC. PMID: 23239929
...The incidence [of accreta] has been rising in recent years. It is one of the important obstetric complications nowadays, leading to significant maternal morbidity and mortality. In the past, this condition was often diagnosed at the time of delivery when massive and unexpected hemorrhage occurred. Hysterectomy, associated with significant physical and psychological consequences, was usually the only management option...[With antenatal diagnosis] The delivery can also be arranged at a favorable time and in an institution where multidisciplinary support is available. Input from a hematologist, interventional radiologist, intensive care physician, urology surgeon, and/or other specialist are desirable. Apart from hysterectomy, various forms of conservative management can also be considered when the diagnosis is made prior to delivery. Fertility can therefore be preserved. After delivery, with or without hysterectomy performed, psychological support to the mothers and their families is essential.
BJOG. 2013 Aug 7. doi: 10.1111/1471-0528.12405. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. Fitzpatrick K, Sellers S, Spark P, Kurinczuk J, Brocklehurst P, Knight M. PMID: 23924326
OBJECTIVE: To describe the management and outcomes of placenta accreta, increta, and percreta in the UK...SETTING: All 221 UK hospitals with obstetrician-led maternity units. POPULATION: All women diagnosed with placenta accreta, increta, and percreta in the UK between May 2010 and April 2011...RESULTS: A cohort of 134 women were identified with placenta accreta, increta, or percreta: 50% (66/133) were suspected to have this condition antenatally. In women with a final diagnosis of placenta increta or percreta, antenatal diagnosis was associated with reduced levels of haemorrhage (median estimated blood loss 2750 versus 6100 ml, P = 0.008) and a reduced need for blood transfusion (59 versus 94%, P = 0.014), possibly because antenatally diagnosed women were more likely to have preventative therapies for haemorrhage (74 versus 52%, P = 0.007), and were less likely to have an attempt made to remove their placenta (59 versus 93%, P < 0.001). Making no attempt to remove any of the placenta, in an attempt to conserve the uterus or prior to hysterectomy, was associated with reduced levels of haemorrhage (median estimated blood loss 1750 versus 3700 ml, P = 0.001) and a reduced need for blood transfusion (57 versus 86%, P < 0.001). 
Cesarean Hysterectomy vs. Uterus-Conserving Treatment

Obstet Gynecol Int. 2012;2012:873929. doi: 10.1155/2012/873929. Epub 2012 May 7. Epidemiology, etiology, diagnosis, and management of placenta accreta. Garmi G, Salim R. PMID: 22645616
...Antenatal diagnosis seems to be a key factor in optimizing maternal outcome...In order to avoid an emergency cesarean and to minimize complications of prematurity it is acceptable to schedule cesarean at 34 to 35 weeks. A multidisciplinary team approach and delivery at a center with adequate resources, including those for massive transfusion are both essential to reduce neonatal and maternal morbidity and mortality. The optimal management after delivery of the neonate is vague since randomized controlled trials and large cohort studies are lacking. Cesarean hysterectomy is probably the preferable treatment. In carefully selected cases, when fertility is desired, conservative management may be considered with caution. The current review discusses the epidemiology, predisposing factors, pathogenesis, diagnostic methods, clinical implications and management options of this condition.
Obstet Gynecol. 2010 Mar;115(3):526-34. doi: 10.1097/AOG.0b013e3181d066d4. Maternal outcome after conservative treatment of placenta accreta. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, Winer N, Pierre F, Benachi A, Dreyfus M, Bauville E, Mahieu-Caputo D, Marpeau L, Descamps P, Goffinet F, Bretelle F. PMID: 20177283
METHODS: This retrospective multicenter study sought to include all women treated conservatively for placenta accreta in tertiary university hospital centers in France from 1993 to 2007. Conservative management was defined by the obstetrician's decision to leave the placenta in situ, partially or totally, with no attempt to remove it forcibly. The primary outcome was success of conservative treatment, defined by uterine preservation. The secondary outcome was a composite measure of severe maternal morbidity including sepsis, septic shock, peritonitis, uterine necrosis, fistula, injury to adjacent organs, acute pulmonary edema, acute renal failure, deep vein thrombophlebitis or pulmonary embolism, or death. RESULTS: Of the 40 university hospitals that agreed to participate in this study, 25 institutions had used conservative treatment at least once (range 1-46) and had treated a total of 167 women. Conservative treatment was successful for 131 of the women (78.4%, 95% confidence interval [CI] 71.4-84.4%); of the remaining 36 women, 18 had primary hysterectomy and 18 had delayed hysterectomy (10.8% each, 95% CI 6.5-16.5%). Severe maternal morbidity occurred in 10 cases (6.0%, 95% CI 2.9-10.7%). One woman died of myelosuppression and nephrotoxicity related to intraumbilical methotrexate administration. Spontaneous placental resorption occurred in 87 of 116 cases (75.0%, 95% CI 66.1-82.6%), with a median delay from delivery of 13.5 weeks (range 4-60 weeks). CONCLUSION: Conservative treatment for placenta accreta can help women avoid hysterectomy and involves a low rate of severe maternal morbidity in centers with adequate equipment and resources.
Acta Obstet Gynecol Scand. 2013 Aug 12. doi: 10.1111/aogs.12230. [Epub ahead of print]
Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization. Chung MY, Cheng YK, Yu SC, Sahota DS, Leung TY. PMID: 23937444
OBJECTIVE: To evaluate the outcome of three different modes of management of abnormally invasive placenta over a 6-year period...POPULATION: In 39 757 deliveries, 25 cases of abnormally invasive placenta were identified at cesarean section...RESULTS: Six women were managed by leaving the placenta in situ and by postoperative uterine artery embolization. Ten women were managed by an extirpative approach and nine women with direct cesarean hysterectomy. The success rate of nonremoval of the placenta with uterine artery embolization was 4/6 (67%). The intraoperative blood loss, blood transfusion requirements and operation times were lowest in the group with nonremoval of the placenta, although a higher secondary complication rate and a longer hospital stay followed. CONCLUSION: Nonremoval of an abnormally invasive placenta at cesarean section and prophylactic postoperative uterine artery embolization are an alternative to elective cesarean hysterectomy.
Arch Gynecol Obstet. 2011 Aug;284(2):491-502. doi: 10.1007/s00404-011-1934-6. Epub 2011 Jun 3.
Invasive placentation and uterus preserving treatment modalities: a systematic review. Steins Bisschop CN, Schaap TP, Vogelvang TE, Scholten PC. PMID: 21638046
PURPOSE: We present a systematic review to evaluate failure rates (secondary hysterectomy or maternal mortality) and success rates (subsequent menstruation or pregnancy) after different uterus preserving treatment modalities in women with invasive placentation. METHODS: A review of English, German or Dutch language-published research, using Medline and Embase databases, was performed. Studies of any design were included. RESULTS: Ten cohort studies and 50 case series or case reports were included. Expectant management reported a secondary hysterectomy in 55/287 (19%), maternal mortality in 1/295 (0.3%), a subsequent menstruation in 44/49 (90%) and a subsequent pregnancy in 24/36 (67%). Embolization of the uterine arteries described a secondary hysterectomy in 8/45 (18%), a subsequent menstruation in 8/13 (62%) and a subsequent pregnancy in 5/33 (15%). Methotrexate therapy presented a secondary hysterectomy in 1/16 (6%), a subsequent menstruation in 4/5 (80%) and a subsequent pregnancy in 1/2 (50%). Uterus preserving surgery showed a secondary hysterectomy in 24/77 (31%), maternal mortality in 2/55 (4%), a subsequent menstruation in 28/34 (82%) and a subsequent pregnancy in 19/26 (73%). CONCLUSIONS: This review indicates that different uterus preserving treatment modalities may be effective in managing invasive placentation. Despite the extensive review of the literature, no conclusions about the superiority of any modality can be drawn.
Accreta Implications of Increasing Cesarean Rates

J Matern Fetal Neonatal Med. 2011 Nov;24(11):1341-6. doi: 10.3109/14767058.2011.553695. Epub 2011 Mar 7. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. PMID: 21381881
...This study's goal was to forecast the effect of rising primary and secondary cesarean rates on annual incidence of placenta previa, placenta accreta, and maternal mortality. METHODS: A decision-analytic model was built using TreeAge Pro software to estimate the future annual incidence of placenta previa, placenta accreta, and maternal mortality using data on national birthing order trends and cesarean and vaginal birth after cesarean rates. Baseline assumptions were derived from the literature, including the likelihood of previa and accreta among women with multiple previous cesarean deliveries. RESULTS: If primary and secondary cesarean rates continue to rise as they have in recent years, by 2020 the cesarean delivery rate will be 56.2%, and there will be an additional 6236 placenta previas, 4504 placenta accretas, and 130 maternal deaths annually. The rise in these complications will lag behind the rise in cesareans by approximately 6 years. CONCLUSIONS: If cesarean rates continue to increase, the annual incidence of placenta previa, placenta accreta, and maternal death will also rise substantially.